LifeCell Makes A Landmark Stride in Making Stem Cell Treatments Possible
~ Records preservation of 50,000 qualified donor cord blood stem cell units ~
Chennai, 22 July 2020:
In its stride towards offering comprehensive stem cell solutions and hope for
treatment of many critical disorders, LifeCell, today announced its remarkable surge in its
community banking inventory by clocking over 50,000 consented and qualified donor stem cell
This inventory, which is set to grow continuously, helps in overcoming the search burden for finding
matching stem cells when needed, by enabling a 97% probability of finding a HLA matching stem cell
unit on a match 1 from the community inventory.
This means a lot to the families who have preserved their babies’ stem cells with LifeCell since there
is almost a complete assurance of finding a matching stem cell from the community inventory.
With the recent expansion, LifeCell will continue to provide affordable and accessible
healthcare to its customers to help expedite their diagnostic journey.
Stem cell transplantation being considered as probably the only treatment options for a wide array
of blood disorders, however there are only about 2,000 stem cell transplants done in India every
year while 80,000 to 1,00,000 annual transplants are required to meet the large burden of blood
cancers and fatal blood disorders in the country 2 . With over 70% of all patients who need a lifesaving
stem cell transplant not being able to find a matching donor in their family 3 the demand for
unrelated donor stem cells is increasing but there aren’t too many of them available. Hence the
chances of finding a donor match is as low as 10% to 15% compared to the West where the chances
are high at around 60% to 70% 2
Hence this milestone further strengthens LifeCell’s Community banking as India’s largest preserved
inventory of cord blood stem cells that acts like a closed donor group for the families that have
preserved their baby's umbilical cord blood stem cells at birth. Additionally, since there are no
restrictions on utilising any number of matching cord blood stem cells units from the community
bank inventory, the entire family including the parents and grandparents can now benefit from the
protection of stem cells at no additional cost when the need arises. For expectant parents, this
inventory strongly establishes the need to preserve their baby’s cord blood stem cells at birth under
community banking for complete protection of their family
Speaking on the milestone, Mayur Abhaya, Managing Director, LifeCell said, "Our community
banking model is aimed to resolve the dearth of matching stem cells when there is a need in the
family. With this landmark milestone, we are confident that our protection extends not just for the
child but the entire family including grandparents. India being highly short on donors, we are glad
that we would be able to offer hope in the unfortunate incident of a critical disorder where there is a
need for matching stem cells"
LifeCell’s community stem cell banking model has been gaining large acceptance and global
recognition for offering matching cord blood stem cells from the common community pool to the
families of the child who require matching stem cells for transplant. With increasing awareness on
the benefits & family protection offered by community banking, LifeCell is confident that it would be
able to build higher inventories thereby further increasing not just the chances but also the number
of available matched units for the families.
Senior Hematologist, Oncologist and Bone Marrow Transplant Specialist Dr. Sandip Shah from
Ahmedabad, Gujarat said, “As a co-author of a research paper co-funded by the ICMR a few yearsago, we had predicted that with an umbilical cord blood registry size of 25,000 donor samples of
Indian origin, >97% Indian patients would find a minimum matching sample. We are happy to see
that LifeCell International not only brought this innovative concept of Community Stem Cell Banking
in India, but have achieved the milestone of over 50,000 qualified and consented cord blood units in
their registry in a short span of three years. Their data is aligned to our predictive model and for
Indian patients who do not have a suitable human leukocyte antigen (HLA)-matched family donor.
Such exclusive unrelated donor registries of banked cord blood units provide the potential for
successful haemopoietic stem-cell transplantation.”
LifeCell, established in 2004, is India39;s leading provider of healthcare services comprising umbilical
cord stem cell banking, diagnostic & therapeutic healthcare solutions. With advanced infrastructure
and facilities at Chennai and Gurugram the company has footprints in over 200 cities in India and
abroad with network presence in over 6000 healthcare institutions.
LifeCell's umbilical cord blood stem cell banking, a community-based approach towards stem cell
access, is a global first initiative that aims to provide families in India better future access to stem
cells than even currently possible in advanced countries such as the US.
As a comprehensive healthcare services provider, LifeCell presents a complete spectrum of services
and products pertaining to mother & baby associated from pregnancy to childbirth. Through these
services, LifeCell aims to provide complete health & wellness for the mother & baby and families.
For more info, visit us at: http://www.lifecell.in
For more information, visit: